0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Testicular cancer -Epidemiology Forecast to 2028
Published Date: March 2019
|
Report Code: DELV-Epid-014
Home | Market Reports | Health | Men s Health
Testicular cancer Epidemiology Forecast to 2028

Testicular cancer -Epidemiology Forecast to 2028

Code: DELV-Epid-014
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Testicular cancer - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Testicular cancer epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Testicular cancer Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Testicular cancer in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Testicular cancer outlook. It also includes the explanation of changing trends of epidemiology outlining the Testicular cancer scenario.

Testicular cancer Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Testicular cancer thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Testicular cancer explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Testicular cancer Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Testicular cancer

Key assessments
• Patient Segmentation in Testicular cancer
• Testicular cancer Risk & Burden
• Factors driving growth in a specific Testicular cancer patient population

1. Report Introduction
2. Testicular cancer Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Testicular cancer in 2016
2.2. Patient Share Distribution of Testicular cancer in 2028
3. Disease Background and Overview: Testicular cancer
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Testicular cancer in 7MM
4.3. Total Prevalent/ Incident Patient Population of Testicular cancer in 7MM – By Countries
5. Epidemiology of Testicular cancer by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Testicular cancer
5.1.3. Sub-Type Specific cases of the Testicular cancer *
5.1.4. Sex- Specific Cases of the Testicular cancer*
5.1.5. Diagnosed Cases of the Testicular cancer
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Testicular cancer
5.4.3. Sub-Type Specific cases of the Testicular cancer*
5.4.4. Sex- Specific Cases of the Testicular cancer*
5.4.5. Diagnosed Cases of the Testicular cancer
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Testicular cancer
5.5.3. Sub-Type Specific cases of the Testicular cancer*
5.5.4. Sex- Specific Cases of the Testicular cancer*
5.5.5. Diagnosed Cases of the Testicular cancer
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Testicular cancer
5.6.3. Sub-Type Specific cases of the Testicular cancer*
5.6.4. Sex- Specific Cases of the Testicular cancer*
5.6.5. Diagnosed Cases of the Testicular cancer
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Testicular cancer
5.7.3. Sub-Type Specific cases of the Testicular cancer*
5.7.4. Sex- Specific Cases of the Testicular cancer*
5.7.5. Diagnosed Cases of the Testicular cancer
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Testicular cancer
5.8.3. Sub-Type Specific cases of the Testicular cancer*
5.8.4. Sex- Specific Cases of the Testicular cancer*
5.8.5. Diagnosed Cases of the Testicular cancer
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Testicular cancer
5.9.3. Sub-Type Specific cases of the Testicular cancer*
5.9.4. Sex- Specific Cases of the Testicular cancer*
5.9.5. Diagnosed Cases of the Testicular cancer
6. Unmet Needs of the Testicular cancer
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Testicular cancer in 7MM
Table 2: Total Prevalent/Incident Cases of the Testicular cancer in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Testicular cancer in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Testicular cancer in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Testicular cancer in United States (2016-2028)*
Table 6: Diagnosed Cases of the Testicular cancer in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Testicular cancer in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Testicular cancer in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Testicular cancer in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Testicular cancer in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Testicular cancer in France (2016-2028)
Table 12: Sub-Type Specific cases of the Testicular cancer in France (2016-2028) *
Table 13: Sex- Specific Cases of the Testicular cancer in France (2016-2028) *
Table 14: Diagnosed Cases of the Testicular cancer in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Testicular cancer in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Testicular cancer in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Testicular cancer in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Testicular cancer in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Testicular cancer in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Testicular cancer in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Testicular cancer in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Testicular cancer in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Testicular cancer in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Testicular cancer in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Testicular cancer in UK (2016-2028) *
Table 26: Diagnosed Cases of the Testicular cancer in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Testicular cancer in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Testicular cancer in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Testicular cancer in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Testicular cancer in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Testicular cancer in 7MM
Figure 2: Total Prevalent/Incident Cases of the Testicular cancer in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Testicular cancer in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Testicular cancer in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Testicular cancer in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Testicular cancer in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Testicular cancer in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Testicular cancer in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Testicular cancer in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Testicular cancer in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Testicular cancer in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Testicular cancer in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Testicular cancer in France (2016-2028) *
Figure 14: Diagnosed Cases of the Testicular cancer in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Testicular cancer in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Testicular cancer in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Testicular cancer in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Testicular cancer in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Testicular cancer in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Testicular cancer in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Testicular cancer in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Testicular cancer in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Testicular cancer in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Testicular cancer in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Testicular cancer in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Testicular cancer in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Testicular cancer in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Testicular cancer in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Testicular cancer in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Testicular cancer in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global and Japan Penile Cancer Market Size Status and Forecast 2021 2027
Global and Japan Penile Cancer Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-3Z6987
Sat Sep 04 00:00:00 UTC 2021

Add to Cart

Global and Japan Penile Cancer Treatment Market Size Status and Forecast 2021 2027
Global and Japan Penile Cancer Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-18N6715
Sat Sep 04 00:00:00 UTC 2021

Add to Cart

Global Testosterone Replacement Therapy Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Testosterone Replacement Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Testosterone Replacement Therapy market size was US 1591.7 million and it is expected to reach US 1187.4 million by the end of 2027 with a CAGR of 4.1 during 20212027.Global Testosterone Replacement Therapy Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-8147
Fri Aug 13 00:00:00 UTC 2021

Add to Cart

Global and Japan Erection Rings Market Insights Forecast to 2027
Global and Japan Erection Rings Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Thu Aug 12 00:00:00 UTC 2021

Add to Cart